S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
OPENLANE, Inc. stock logo
KAR
OPENLANE
$17.00
-0.5%
$16.11
$12.86
$17.70
$1.84B1.45731,563 shs1.06 million shs
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
$3.22
+3.5%
$3.22
$1.58
$6.94
$648.31MN/A1.24 million shs3.62 million shs
Paramount Resources Ltd. stock logo
POU
Paramount Resources
C$29.15
+1.2%
C$28.00
C$24.59
C$33.80
C$4.21B3.31260,244 shs299,374 shs
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.05
$0.05
$0.25
$3.56
$1.42M2.34455,220 shs44,803 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
OPENLANE, Inc. stock logo
KAR
OPENLANE
-0.32%-2.71%+3.61%+21.64%+25.44%
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
0.00%0.00%0.00%0.00%0.00%
Paramount Resources Ltd. stock logo
POU
Paramount Resources
-0.03%-4.35%+8.03%+13.12%-11.55%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00%+7.07%+3.63%+11.11%-99.25%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
OPENLANE, Inc. stock logo
KAR
OPENLANE
4.1315 of 5 stars
2.32.00.02.42.93.33.1
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/AN/AN/AN/AN/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
3.7912 of 5 stars
3.40.02.50.01.82.52.5
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
OPENLANE, Inc. stock logo
KAR
OPENLANE
2.50
Moderate Buy$19.5014.74% Upside
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
2.70
Moderate BuyC$34.1517.15% Upside
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/A

Current Analyst Ratings

Latest MCF, POU, SEPL, KAR, and SQZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/19/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$37.50 ➝ C$40.00
4/10/2024
OPENLANE, Inc. stock logo
KAR
OPENLANE
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$16.00 ➝ $20.00
4/9/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$37.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperformC$30.00 ➝ C$29.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutralC$32.50 ➝ C$30.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
ATB Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperformC$37.00 ➝ C$36.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector PerformC$33.00 ➝ C$32.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperformC$40.00 ➝ C$37.50
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuyC$33.50 ➝ C$33.00
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Market PerformC$40.00 ➝ C$37.50
3/7/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$33.00 ➝ C$31.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
OPENLANE, Inc. stock logo
KAR
OPENLANE
$1.65B1.12$1.96 per share8.66$12.28 per share1.38
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/AN/AN/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
C$1.80B2.34C$0.06 per share512.50C$24.20 per share1.20
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$18.16M0.08N/AN/A$1.94 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
OPENLANE, Inc. stock logo
KAR
OPENLANE
-$154.10M-$1.83N/A17.000.93-9.37%7.49%2.11%5/1/2024 (Confirmed)
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/A0.00N/AN/AN/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
C$470.20MC$3.179.200.1426.13%13.67%6.77%5/1/2024 (Estimated)
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/A

Latest MCF, POU, SEPL, KAR, and SQZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
OPENLANE, Inc. stock logo
KAR
OPENLANE
$0.21N/A-$0.21N/AN/AN/A  
3/6/2024Q4 2023
Paramount Resources Ltd. stock logo
POU
Paramount Resources
C$0.95C$0.75-C$0.20C$0.75C$436.00 millionC$470.50 million
2/20/2024Q4 2023
OPENLANE, Inc. stock logo
KAR
OPENLANE
$0.13$0.16+$0.03$0.30$392.56 million$391.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
OPENLANE, Inc. stock logo
KAR
OPENLANE
N/AN/AN/AN/AN/A
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/AN/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
C$1.505.15%N/A47.32%N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/A

Latest MCF, POU, SEPL, KAR, and SQZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
MonthlyC$0.135.46%4/12/20244/15/20244/30/2024
3/6/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
MonthlyC$0.135.46%3/14/20243/15/20243/28/2024
2/14/2024
Paramount Resources Ltd. stock logo
POU
Paramount Resources
MonthlyC$0.135.66%2/14/20242/29/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
OPENLANE, Inc. stock logo
KAR
OPENLANE
0.15
1.15
1.15
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/AN/AN/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
0.83
0.71
0.68
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/A
3.50
3.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
OPENLANE, Inc. stock logo
KAR
OPENLANE
99.76%
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
11.68%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
38.51%

Insider Ownership

CompanyInsider Ownership
OPENLANE, Inc. stock logo
KAR
OPENLANE
2.74%
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/A
Paramount Resources Ltd. stock logo
POU
Paramount Resources
45.91%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
16.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
OPENLANE, Inc. stock logo
KAR
OPENLANE
4,500108.05 million105.09 millionOptionable
Contango Oil & Gas Company stock logo
MCF
Contango Oil & Gas
N/A201.34 millionN/ANot Optionable
Paramount Resources Ltd. stock logo
POU
Paramount Resources
579144.40 millionN/ANot Optionable
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
5329.49 million24.77 millionNot Optionable

MCF, POU, SEPL, KAR, and SQZ Headlines

SourceHeadline
VC funding update: who raised money in March?VC funding update: who raised money in March?
bizjournals.com - April 1 at 11:06 AM
SQZ, Portal founder Armon Sharei on starting over in biotechSQZ, Portal founder Armon Sharei on starting over in biotech
biopharmadive.com - March 26 at 10:35 AM
Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
finance.yahoo.com - March 19 at 10:20 AM
SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to StemcellSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell
fiercebiotech.com - March 1 at 10:56 AM
Rx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and moreRx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and more
mmm-online.com - February 16 at 8:05 AM
SQZB SQZ Biotechnologies CompanySQZB SQZ Biotechnologies Company
seekingalpha.com - December 28 at 1:42 PM
SQZ Biotechnologies Co Ordinary Shares SQZBSQZ Biotechnologies Co Ordinary Shares SQZB
morningstar.com - December 12 at 8:37 PM
SQZ founder Armon Sharei opens Portal to to simplify intracellular deliverySQZ founder Armon Sharei opens Portal to to simplify intracellular delivery
fiercebiotech.com - December 12 at 10:35 AM
Medicine at a bigger scale: FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site'Medicine at a bigger scale': FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site
wral.com - November 11 at 8:41 PM
‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%
fiercebiotech.com - November 9 at 10:34 AM
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - November 8 at 6:33 PM
SQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0M
msn.com - November 8 at 6:33 PM
Lifeline Biotechnologies Inc LLBOLifeline Biotechnologies Inc LLBO
morningstar.com - November 4 at 11:41 PM
SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 3 at 7:42 PM
SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - August 10 at 9:16 PM
Sqz Biotechnologies Co (SQZB)Sqz Biotechnologies Co (SQZB)
investing.com - August 3 at 7:45 AM
Roche declines to take up option on SQZ Bio’s SQZ-APC-HPV programRoche declines to take up option on SQZ Bio’s SQZ-APC-HPV program
thepharmaletter.com - July 27 at 12:11 AM
Roche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ BiotechnologiesRoche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ Biotechnologies
precisionmedicineonline.com - July 25 at 10:53 PM
Roche Decides Not to Exercise Solid Tumor Option with SQZRoche Decides Not to Exercise Solid Tumor Option with SQZ
biospace.com - July 25 at 10:53 PM
SQZ Biotechnologies Provides Update on Collaboration with RocheSQZ Biotechnologies Provides Update on Collaboration with Roche
benzinga.com - July 25 at 12:37 PM
Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurchRoche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch
pharmaceutical-technology.com - July 25 at 12:37 PM
Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)
knoxdaily.com - July 5 at 1:10 PM
SQZ Biotechnologies to be delisted from the NYSESQZ Biotechnologies to be delisted from the NYSE
seekingalpha.com - July 3 at 11:23 PM
NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)
finance.yahoo.com - July 3 at 6:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

OPENLANE logo

OPENLANE

NYSE:KAR
OPENLANE, Inc., together with its subsidiaries, operates as a digital marketplace for used vehicles, which connects sellers and buyers in North America, Europe, the Philippines, and Uruguay. The company operates through two segments, Marketplace and Finance. The Marketplace segment offers digital marketplace services for buying and selling used vehicles. Its digital marketplaces include OPENLANE, a mobile-app enabled solutions that allows dealers to sell and source inventory in the United States. This segment also provides value-added ancillary services, including inbound and outbound transportation logistics, reconditioning, vehicle inspection and certification, titling, administrative, and collateral recovery services. This segment sells its products and services through vehicle manufacturers, fleet companies, rental car companies, finance companies, and others. The Finance segment offers floorplan financing, a short-term inventory-secured financing to independent used vehicle dealers. The company serves commercial customers and dealer customers. The company was formerly known as KAR Auction Services, Inc. and changed its name to OPENLANE, Inc. in May 2023. OPENLANE, Inc. was incorporated in 2006 and is headquartered in Carmel, Indiana.
Contango Oil & Gas logo

Contango Oil & Gas

NYSE:MCF
Contango Oil & Gas Company is a Fort Worth, Texas based, independent oil and natural gas company whose business is to maximize production and cash flow from its offshore properties in the shallow waters of the Gulf of Mexico and onshore properties in Texas, Oklahoma, Wyoming, and Louisiana and, when determined appropriate, to use that cash flow to explore, develop, and increase production from its existing properties, to acquire additional PDP-heavy crude oil and natural gas properties or to pay down debt.
Paramount Resources logo

Paramount Resources

TSE:POU
Paramount Resources Ltd. explores for and develops conventional and unconventional petroleum and natural gas reserves and resources in Canada. The company holds interests in the Karr and Wapiti Montney properties covering an area of 109,000 net acres located south of the city of Grande Prairie, Alberta; Kaybob North Duvernay development and natural gas producing properties covering an area of 124,000 net acres located in west-central Alberta; and Willesden Green Duvernay development in central Alberta and shale gas producing properties in the Horn River Basin in northeast British Columbia covering an area of 249,000 net acres. The company was founded in 1976 and is based in Calgary, Canada.
SQZ Biotechnologies logo

SQZ Biotechnologies

NYSE:SQZ
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.